Duodenal Villous Atrophy in a TTG-Negative Patient Taking Olmesartan: A Case Report and Review of the Literature
Olmesartan, an angiotensin II receptor antagonist used to treat hypertension, is associated with few adverse effects. Here, a case of severe sprue-like enteropathy and acute kidney injury is described in a 68-year-old male taking olmesartan for 3-4 years. He presented to hospital with a five-week hi...
Saved in:
Main Authors: | Tasha Kulai, Thomas Arnason, Donald MacIntosh, John Igoe |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2016-01-01
|
Series: | Canadian Journal of Gastroenterology and Hepatology |
Online Access: | http://dx.doi.org/10.1155/2016/6091571 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Seronegative Intestinal Villous Atrophy: A Diagnostic Challenge
by: Cláudio Martins, et al.
Published: (2016-01-01) -
Accurate Diagnosis of Villous Atrophy in Celiac Disease Using Confocal Laser Endomicroscopy
by: Miriam Fort Gasia, et al.
Published: (2014-01-01) -
Evaluating the Correlation between High Titers of Tissue-Transglutaminase Antibody with the Grade of Severity of Villous Atrophy in Syrian Patients with Celiac Disease
by: A. Alhabbal, et al.
Published: (2022-05-01) -
Villous Adenoma of Papilla of Vater
by: SR Choudhury, et al.
Published: (1990-01-01) -
Olmesartan Associated Sprue-Like Enteropathy and Colon Perforation
by: Mahmoud Abdelghany, et al.
Published: (2014-01-01)